Takeda Pharmaceutical (TAK) Treasury Shares (2018 - 2026)

Takeda Pharmaceutical's Treasury Shares history runs 9 years deep, the most recent figure standing at -$313.3 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 36.12% year-over-year to -$313.3 million; the TTM figure through Mar 2026 stood at -$313.3 million (up 36.12% YoY), while the FY2026 annual figure was -$326.4 million, up 33.55% from the prior year.
• Treasury Shares was -$313.3 million for Q1 2026 at Takeda Pharmaceutical, up from -$319.2 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $274426.1 in Q1 2022 to a low of $92886.0 in Q1 2019.
• Historically, Treasury Shares has averaged $174247.0 across 5 years, with a median of $170904.3 in 2020.
• The sharpest annual moves came in 2022 and 2025: Treasury Shares surged 77.42% in 2022, then sank 241.78% in 2025.
• A 5-year view of Treasury Shares shows it stood at -$710.1 million in 2022, then jumped by 51.17% to -$346.7 million in 2023, then jumped by 52.89% to -$163.4 million in 2024, then plunged by 95.4% to -$319.2 million in 2025, then increased by 1.86% to -$313.3 million in 2026.
• The last three Treasury Shares figures came in at -$313.3 million (Q1 2026), -$319.2 million (Q4 2025), and -$333.4 million (Q3 2025), per Business Quant data.